A 79-year-old female resident of an assisted living facility receives care from a community nurse on a regular basis for treatment of a chronic venous leg ulcer
Which of the following factors would the nurse be most justified in ruling out as a contributing factor to the client's impaired wound healing?
A)
A lower skin collagen content than in younger adults
B)
Decreased fibroblast synthesis
C)
Slow reepithelialization
D)
Decreased antibody levels
Ans:
D
Feedback:
Older adults do not normally have diminished antibody levels. Low collagen levels, decreased fibroblast activity, and slow reepithelialization are common impediments to wound healing in the elderly.
You might also like to view...
A 60-year-old woman has developed reflexive sympathetic dystrophy after arthroscopic repair of her shoulder. A key feature of this condition is that the:
a. Affected extremity will eventually regain its function. b. Pain is felt at one site but originates from another location. c. Patient's pain will be associated with nausea, pallor, and diaphoresis. d. Slightest touch, such as a sleeve brushing against her arm, causes severe and intense pain.
When taking anticoagulants, clients should be instructed to avoid large portions of:
1. Meat and poultry. 2. Aged meat and cheese. 3. Yellow vegetables and squash. 4. Green, leafy vegetables.
A nurse is interviewing a client who is a survivor of abuse. The client is telling the nurse about how the violence occurred. Which statement would the nurse interpret as reflecting phase 3 of the cycle of violence?
A) "He threw me against the wall and started punching my face." B) "He yells at me for not having dinner waiting for him when he came home." C) "He calls me stupid and incompetent, asking himself why he ever married me." D) "He tells me that he is sorry and that he will never hit me again."
The physician has written an order for a client for a new antihypertensive drug. Why is it important that the nurse have an understanding of the drug's prototype?
1. Knowledge of the prototype allows the nurse to surmise important information about an unfamiliar drug in the same class. 2. If the nurse knows the actions and adverse effects of the prototype drug, this information can be relevant to use of the unfamiliar drug. 3. The safety profile for the prototype is the same as the safety profile for the unfamiliar drug. 4. Knowledge of the prototype drug's therapeutic or pharmacologic classification can offer useful information about the unfamiliar drug. 5. Traditional prototype drugs are often older and infrequently prescribed, and the information about them should not be used.